Virbac SA
Open
SectorHealthcare
341 1.34
Overview
Share price change
24h
Min
334
Max
341.5
Income | -14M 68M |
|---|---|
Sales | -12M 726M |
P/E Sector Avg | 18.906 50.958 |
Dividend yield | 0.44 |
Profit margin | 9.427 |
Employees | 6,442 |
EBITDA | -35M 121M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +23.7% upside |
Dividend yield Sector Avg | 0.44% 2.41% |
|---|---|
Next Earnings | 17 wrz 2026 |
Market Cap | 52M 2.9B |
|---|---|
Previous open | 339.66 |
Previous close | 341 |
News Sentiment
By Acuity
18%
82%
35 / 342 Ranking in Healthcare
Virbac SA Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
